News and Events


Dr. Kathryn Nelson, principle scientist in the Walters laboratory, was recently interviewed for an article in the Washington Post raises doubts about recent claims that curcumin, a compound found in turmeric, may be effective in fighting arthritis, depression, and even cancer. As the article states, "If turmeric does have benefits, Nelson suggests, curcumin may not be the compound that delivers them. 'There are things that can fool you into thinking a compound is active when it’s not,' she says.

Dr. Michael Walters is cited in a recent article by the Daily Express questioning claims that curcumin, a chemical found in turmeric, could be beneficial for the treatment of Alzheimer's disease, diabetes, and obesity. Read the full article here.

A recent article by Bloomberg titled "Why We Can't Have the Male Pill" makes reference to the University's efforts, headed by Dr. Gunda Georg, to create a new male contraceptive that targets sperm directly.  Read the full article here.

Congratulations to faculty members who were recently awarded grants for their ongoing research!:

Congratulations to Dr. Peter Dosa who was promoted to Affiliate Research Associate Professor!

Dr. Gunda Georg has been selected for induction into the Medicinal Chemistry Hall of Fame, Class of 2017. The induction recognizes her as a pioneer who has made impactful discoveries in the field of medicinal chemistry. She will be recognized at the Fall American Chemical Society meeting on August 22nd in Washington D.C.

Josh Shirley, a graduate student in the Department of Medicinal Chemistry, is the winner of the Outstanding TA Award for 20162017 as presented by the College of Pharmacy's Office of Teaching, Learning, and Assessment. 

Staff member Ann Howarth was awarded a Meritorious Service Award for excellent work in the Department of Medicinal Chemistry in 2016. The award ceremony took place during the 15th Annual College of Pharmacy Employee Day held on June 1st at the Glensheen Mansion in Duluth. Ann Howarth is the Executive Office and Administrative Specialist for laboratories in the Cancer and Cardiovascular Research Building for Medicinal Chemistry.

After a five-year phased retirement, Professor Yusuf Abul-Hajj is set to retire June 30. A faculty member since 1968, Dr. Abul-Hajj has served in many leadership positions, including head of the Department of Medicinal Chemistry for 21 years. Under his leadership, Medicinal Chemistry became one of the top ranked departments in the country and prepared numerous future medicinal chemists.